Accuray Incorporated Logo

Accuray Incorporated

0H8I.L

(0.0)
Stock Price

1,91 USD

-1.62% ROA

-28.12% ROE

-40.46x PER

Market Cap.

276.568.405,00 USD

333.29% DER

0% Yield

-3.25% NPM

Accuray Incorporated Stock Analysis

Accuray Incorporated Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Accuray Incorporated Fundamental Stock Analysis
# Analysis Rating
1 ROE

Unidentified ROE

2 ROA

Unidentified ROA

3 PBV

Unidentified ROA

4 DER

Unidentified DER

5 Revenue Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

6 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

7 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

8 Graham Number

Unidentified Graham Number

9 Dividend Growth

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

10 Dividend

No dividends from the company in the past three years raises doubts about its profitability for shareholders.

11 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock seems overpriced (0), indicating a potential drawback for investors as its market price exceeds its estimated intrinsic value.

Accuray Incorporated Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Accuray Incorporated Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Sell
4 Stoch RSI Sell

Accuray Incorporated Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Accuray Incorporated Revenue
Year Revenue Growth
2012 315.974.000
2013 369.419.000 14.47%
2014 379.801.000 2.73%
2015 398.800.000 4.76%
2016 383.414.000 -4.01%
2017 404.897.000 5.31%
2018 418.785.000 3.32%
2019 382.928.000 -9.36%
2020 396.289.000 3.37%
2021 429.909.000 7.82%
2022 447.605.000 3.95%
2023 415.568.000 -7.71%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Accuray Incorporated Research and Development Expenses
Year Research and Development Expenses Growth
2012 66.197.000
2013 53.724.000 -23.22%
2014 55.752.000 3.64%
2015 56.652.000 1.59%
2016 49.921.000 -13.48%
2017 57.251.000 12.8%
2018 56.493.000 -1.34%
2019 49.784.000 -13.48%
2020 52.729.000 5.59%
2021 57.752.000 8.7%
2022 57.129.000 -1.09%
2023 56.052.000 -1.92%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Accuray Incorporated General and Administrative Expenses
Year General and Administrative Expenses Growth
2012 48.626.000
2013 45.335.000 -7.26%
2014 46.379.000 2.25%
2015 50.122.000 7.47%
2016 43.766.000 -14.52%
2017 48.136.000 9.08%
2018 49.577.000 2.91%
2019 40.144.000 -23.5%
2020 41.723.000 3.78%
2021 44.391.000 6.01%
2022 48.271.000 8.04%
2023 52.092.000 7.34%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Accuray Incorporated EBITDA
Year EBITDA Growth
2012 -45.991.000
2013 2.420.000 2000.45%
2014 -7.576.000 131.94%
2015 5.423.000 239.7%
2016 8.220.000 34.03%
2017 5.935.000 -38.5%
2018 11.074.000 46.41%
2019 20.080.000 44.85%
2020 28.624.000 29.85%
2021 13.661.000 -109.53%
2022 6.909.000 -97.73%
2023 13.856.000 50.14%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Accuray Incorporated Gross Profit
Year Gross Profit Growth
2012 97.640.000
2013 142.800.000 31.62%
2014 145.402.000 1.79%
2015 158.713.000 8.39%
2016 141.341.000 -12.29%
2017 161.695.000 12.59%
2018 162.651.000 0.59%
2019 149.721.000 -8.64%
2020 159.507.000 6.14%
2021 159.955.000 0.28%
2022 153.960.000 -3.89%
2023 157.972.000 2.54%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Accuray Incorporated Net Profit
Year Net Profit Growth
2012 -97.361.000
2013 -35.448.000 -174.66%
2014 -40.209.000 11.84%
2015 -25.504.000 -57.66%
2016 -29.579.000 13.78%
2017 -23.899.000 -23.77%
2018 -16.430.000 -45.46%
2019 3.827.000 529.32%
2020 -6.311.000 160.64%
2021 -5.347.000 -18.03%
2022 -9.280.000 42.38%
2023 -11.876.000 21.86%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Accuray Incorporated Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2012 -1
2013 0 0%
2014 -1 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Accuray Incorporated Free Cashflow
Year Free Cashflow Growth
2012 -81.303.000
2013 -11.585.000 -601.8%
2014 -24.854.000 53.39%
2015 22.859.000 208.73%
2016 -5.411.000 522.45%
2017 12.055.000 144.89%
2018 -33.952.000 135.51%
2019 -5.027.000 -575.39%
2020 36.192.000 113.89%
2021 -7.117.000 608.53%
2022 2.925.000 343.32%
2023 -9.683.000 130.21%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Accuray Incorporated Operating Cashflow
Year Operating Cashflow Growth
2012 -66.177.000
2013 346.000 19226.3%
2014 -14.409.000 102.4%
2015 30.925.000 146.59%
2016 -380.000 8238.16%
2017 18.331.000 102.07%
2018 -29.641.000 161.84%
2019 -1.469.000 -1917.77%
2020 38.512.000 103.81%
2021 -2.400.000 1704.67%
2022 15.539.000 115.45%
2023 -8.591.000 280.88%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Accuray Incorporated Capital Expenditure
Year Capital Expenditure Growth
2012 15.126.000
2013 11.931.000 -26.78%
2014 10.445.000 -14.23%
2015 8.066.000 -29.49%
2016 5.031.000 -60.33%
2017 6.276.000 19.84%
2018 4.311.000 -45.58%
2019 3.558.000 -21.16%
2020 2.320.000 -53.36%
2021 4.717.000 50.82%
2022 12.614.000 62.61%
2023 1.092.000 -1055.13%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Accuray Incorporated Equity
Year Equity Growth
2012 106.835.000
2013 98.548.000 -8.41%
2014 75.780.000 -30.04%
2015 59.660.000 -27.02%
2016 46.533.000 -28.21%
2017 48.632.000 4.32%
2018 49.871.000 2.48%
2019 63.635.000 21.63%
2020 68.840.000 7.56%
2021 53.189.000 -29.43%
2022 53.659.000 0.88%
2023 50.944.000 -5.33%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Accuray Incorporated Assets
Year Assets Growth
2012 475.929.000
2013 495.188.000 3.89%
2014 466.773.000 -6.09%
2015 469.033.000 0.48%
2016 406.464.000 -15.39%
2017 378.727.000 -7.32%
2018 438.181.000 13.57%
2019 490.927.000 10.74%
2020 480.098.000 -2.26%
2021 472.849.000 -1.53%
2022 479.214.000 1.33%
2023 476.830.000 -0.5%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Accuray Incorporated Liabilities
Year Liabilities Growth
2012 369.094.000
2013 396.640.000 6.94%
2014 390.993.000 -1.44%
2015 409.373.000 4.49%
2016 359.931.000 -13.74%
2017 330.095.000 -9.04%
2018 388.310.000 14.99%
2019 427.292.000 9.12%
2020 411.258.000 -3.9%
2021 419.660.000 2%
2022 425.555.000 1.39%
2023 425.886.000 0.08%

Accuray Incorporated Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
4.71
Net Income per Share
-0.07
Price to Earning Ratio
-40.46x
Price To Sales Ratio
0.61x
POCF Ratio
39.86
PFCF Ratio
-49.99
Price to Book Ratio
5.4
EV to Sales
0.44
EV Over EBITDA
17.55
EV to Operating CashFlow
28.93
EV to FreeCashFlow
-36.09
Earnings Yield
-0.02
FreeCashFlow Yield
-0.02
Market Cap
0,28 Bil.
Enterprise Value
0,20 Bil.
Graham Number
0.91
Graham NetNet
-2.24

Income Statement Metrics

Net Income per Share
-0.07
Income Quality
-1.02
ROE
-0.13
Return On Assets
-0.03
Return On Capital Employed
0
Net Income per EBT
1.37
EBT Per Ebit
-11.71
Ebit per Revenue
0
Effective Tax Rate
-0.37

Margins

Sales, General, & Administrative to Revenue
0.11
Research & Developement to Revenue
0.13
Stock Based Compensation to Revenue
0.02
Gross Profit Margin
0.34
Operating Profit Margin
0
Pretax Profit Margin
-0.02
Net Profit Margin
-0.03

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
0.07
Free CashFlow per Share
-0.06
Capex to Operating CashFlow
-1.8
Capex to Revenue
-0.03
Capex to Depreciation
-0.98
Return on Invested Capital
0.08
Return on Tangible Assets
-0.02
Days Sales Outstanding
62.07
Days Payables Outstanding
42.99
Days of Inventory on Hand
184.85
Receivables Turnover
5.88
Payables Turnover
8.49
Inventory Turnover
1.97
Capex per Share
-0.13

Balance Sheet

Cash per Share
0,80
Book Value per Share
0,53
Tangible Book Value per Share
-0.07
Shareholders Equity per Share
0.53
Interest Debt per Share
1.76
Debt to Equity
3.33
Debt to Assets
0.36
Net Debt to EBITDA
-6.76
Current Ratio
1.66
Tangible Asset Value
-0,01 Bil.
Net Current Asset Value
-0,09 Bil.
Invested Capital
3.33
Working Capital
0,13 Bil.
Intangibles to Total Assets
0.12
Average Receivables
0,08 Bil.
Average Payables
0,03 Bil.
Average Inventory
147563500
Debt to Market Cap
0.61

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Accuray Incorporated Dividends
Year Dividends Growth

Accuray Incorporated Profile

About Accuray Incorporated

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the Americas, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body, such as prostate, lung, brain, spine, liver, pancreas, and kidney. The company also provides the TomoTherapy System, including the Radixact System, which consists of an integrated radiation therapy system designed for the treatment of a range of cancer types. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Sunnyvale, California.

CEO
Ms. Suzanne Winter M.B.A.
Employee
1.024
Address
1310 Chesapeake Terrace
Sunnyvale, 94089

Accuray Incorporated Executives & BODs

Accuray Incorporated Executives & BODs
# Name Age
1 Mr. Jesse Chew
Senior Vice President, Chief Legal Officer & Company Secretary
70
2 Mr. John M. Dunn
Vice President, Chief Information & Security Officer
70
3 Ms. Gina Corradetti
Vice President, Chief Accounting Officer, Principal Accounting Officer & Controller
70
4 Ms. Melanie Gebauer
Vice President of Global Human Resources
70
5 Mr. Ali Pervaiz
Senior Vice President & Chief Financial Officer
70
6 Ms. Suzanne Winter M.B.A.
President, Chief Executive Officer & Director
70
7 Mr. Michael Hoge
Senior Vice President of Global Operations
70
8 Beth Kaplan
Public Relations Director
70
9 Mr. Juki Hozumi
President & GM of Japan Region
70
10 Mr. Sandeep Chalke
Senior Vice President & Chief Commercial Officer
70

Accuray Incorporated Competitors